Caligan Partners LP
26 holdingsFiling period: 2026-03-31Current AUM: $2.18Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | LQDA | LIQUIDIA CORPORATION | 8.12M | $306.4M | $682.9M | 31.27% | -- | 2026-03-31 |
| 2 | RVMD | REVOLUTION MEDICINES INC | 1.88M | $183.0M | $352.9M | 16.16% | +597.8K | 2026-03-31 |
| 3 | ABVX | ABIVAX SA | 1.46M | $162.8M | $182.6M | 8.36% | +10.0K | 2026-03-31 |
| 4 | PCVX | VAXCYTE INC | 2.06M | $119.7M | $111.4M | 5.10% | +355.9K | 2026-03-31 |
| 5 | XENE | XENON PHARMACEUTICALS INC | 1.39M | $81.0M | $87.3M | 4.00% | +293.7K | 2026-03-31 |
| 6 | MLYS | MINERALYS THERAPEUTICS INC | 2.77M | $75.1M | $70.8M | 3.24% | -2,298,400 | 2026-03-31 |
| 7 | EXEL | EXELIXIS INC | 1.55M | $66.6M | $82.4M | 3.77% | -- | 2026-03-31 |
| 8 | CGON | CG ONCOLOGY INC | 900.0K | $60.9M | $64.1M | 2.93% | -- | 2026-03-31 |
| 9 | TNGX | TANGO THERAPEUTICS INC | 2.41M | $50.4M | $65.5M | 3.00% | -1,321,097 | 2026-03-31 |
| 10 | TYRA | TYRA BIOSCIENCES INC | 1.28M | $48.9M | $40.7M | 1.86% | +332.7K | 2026-03-31 |
| 11 | ADMA | ADMA BIOLOGICS INC | 5.06M | $45.6M | $42.8M | 1.96% | +2.04M | 2026-03-31 |
| 12 | SYRE | SPYRE THERAPEUTICS INC | 878.1K | $44.3M | $86.3M | 3.95% | -- | 2026-03-31 |
| 13 | LBRX | LB PHARMACEUTICALS INC | 1.44M | $34.6M | $56.3M | 2.58% | -- | 2026-03-31 |
| 14 | VOR | VOR BIOPHARMA INC | 1.93M | $34.3M | $40.7M | 1.86% | +1000.0K | 2026-03-31 |
| 15 | SABS | SAB BIOTHERAPEUTICS INC | 7.97M | $30.5M | $28.4M | 1.30% | -- | 2026-03-31 |
| 16 | IRD | OPUS GENETICS INC | 6.08M | $27.6M | $22.5M | 1.03% | -- | 2026-03-31 |
| 17 | IVA | INVENTIVA SA | 4.97M | $27.6M | $22.3M | 1.02% | +2.97M | 2026-03-31 |
| 18 | MBX | MBX BIOSCIENCES INC | 848.6K | $25.3M | $55.9M | 2.56% | -- | 2026-03-31 |
| 19 | AVTX | AVALO THERAPEUTICS INC | 1.64M | $24.4M | $29.8M | 1.37% | +753.5K | 2026-03-31 |
| 20 | ANIK | ANIKA THERAPEUTICS INC | 1.44M | $20.8M | $27.7M | 1.27% | -- | 2026-03-31 |
| 21 | MAZE | MAZE THERAPEUTICS INC | 615.0K | $18.4M | $16.6M | 0.76% | +64.8K | 2026-03-31 |
| 22 | VRCA | VERRICA PHARMACEUTICALS INC | 923.9K | $4.9M | $4.8M | 0.22% | -- | 2026-03-31 |
| 23 | SNSE | SENSEI BIOTHERAPEUTICS INC | 126.0K | $4.0M | $4.0M | 0.18% | -- | 2026-03-31 |
| 24 | AGIO | AGIOS PHARMACEUTICALS INC | 90.0K | $3.0M | $2.7M | 0.12% | -- | 2026-03-31 |
| 25 | AURA | AURA BIOSCIENCES INC | 229.9K | $1.5M | $1.6M | 0.07% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2